{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:13:38Z","timestamp":1761488018483},"reference-count":46,"publisher":"Microbiology Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4,1]]},"abstract":"<jats:p>A 10-year invasive pneumococcal disease (IPD) enhanced surveillance project in the Oxfordshire region of the UK between 1996 and 2005 identified a total of 2691 <jats:italic>Streptococcus pneumoniae<\/jats:italic> isolates from all ages that provided a comprehensive description of pneumococcal epidemiology. All isolates were serotyped and those from children under 5 years of age were genotyped and a matched case\u2013control study using adults hospitalized between 1995 and 2000 was performed to estimate the effectiveness of the pneumococcal polysaccharide vaccine in the local population. Fifty-one serotypes were isolated, with different age distributions. The overall incidence of IPD was 9.2 cases per 100\u200a000 population per annum [95\u200a% confidence interval (CI), 8.6\u20139.9] and that of meningitis was 0.7 per 100\u200a000 population per annum (95\u200a% CI 0.5\u20130.9). After adjusting for age, serotype 1 was found to be less likely to be associated with meningitis versus other IPD, compared with the most common serotype 14, whereas serotype 12F was more likely to cause meningitis than other IPD. There were significant temporal changes in IPD incidence of four serotypes, with decreases in serotypes 1, 12F and 14 and increases in serotype 8. A possible novel variant (from serotype 6A to 6B) was found using multilocus sequence typing analysis. From the matched case\u2013control study of adults, the pneumococcal polysaccharide vaccine effectiveness was estimated to be 43\u200a% (2\u201368\u200a%), which did not change significantly after adjustment for pre-existing co-morbidities. The data provide a baseline against which the impact of the pneumococcal conjugate vaccine introduced in the UK in 2006 could be measured.<\/jats:p>","DOI":"10.1099\/jmm.0.47690-0","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T19:20:00Z","timestamp":1205868000000},"page":"480-487","source":"Crossref","is-referenced-by-count":32,"title":["Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England"],"prefix":"10.1099","volume":"57","author":[{"given":"Dona","family":"Foster","sequence":"first","affiliation":[{"name":"Thames Valley Health Protection Unit, Health Protection Agency, Oxford, UK"},{"name":"Nuffield Department of Clinical Laboratory Science, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Knox","sequence":"additional","affiliation":[{"name":"Division of Public Health and Primary Health Care, University of Oxford, Headington, Oxford OX3 7LF, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. S.","family":"Walker","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. T.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Laboratory Science, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel","family":"Moore","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Laboratory Science, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Haworth","sequence":"additional","affiliation":[{"name":"Thames Valley Health Protection Unit, Health Protection Agency, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Peto","sequence":"additional","affiliation":[{"name":"Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela B.","family":"Brueggemann","sequence":"additional","affiliation":[{"name":"Department of Zoology, University of Oxford, Oxford OX1 3PS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derrick W.","family":"Crook","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Laboratory Science, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Oxford Invasive Pneumococcal Surveillance Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1469-0691.2006.01544.x","article-title":"Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971\u20132004) and serotype coverage by marketed pneumococcal vaccines","volume":"12","author":"Akduman","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/JCM.44.3.999-1017.2006","article-title":"Pre- and postvaccination clonal compositions of invasive pneumococcal serotypes for isolates collected in the United States in 1999, 2001 and 2002","volume":"44","author":"Beall","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijantimicag.2004.09.016","article-title":"Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Group A \u03b2 -haemolytic streptococci in 2002-2003 results of the multinational GRASP Surveillance Program","volume":"25","author":"Beekmann","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R4","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1128\/JCM.43.4.2004-2008.2005","article-title":"Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men","volume":"43","author":"Birtles","year":"2005","journal-title":"J Clin Microbiol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R6","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1128\/JCM.41.11.4966-4970.2003","article-title":"Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates","volume":"41","author":"Brueggemann","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R7","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"R8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1086\/430604","article-title":"Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West: emergence of nonvaccine serogroups","volume":"41","author":"Byington","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R9","first-page":"72","article-title":"Outbreak of invasive pneumococcal disease \u2013 Alaska, 2003\u20132004","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R10","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1016\/j.vaccine.2003.08.050","article-title":"The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials","volume":"22","author":"Conaty","year":"2004","journal-title":"Vaccine"},{"key":"R11","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"key":"R12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1086\/313645","article-title":"An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel","volume":"30","author":"Dagan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.inf.0000069761.11093.c3","article-title":"Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers","volume":"22","author":"Dagan","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R14","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults (Review)","volume":"4","author":"Dear","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R15","article-title":"Immunisation against Infectious Disease \u2013 \u201cThe Green Book\u201d","volume":"25","year":"2006","journal-title":"Chapter"},{"key":"R16","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae : identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"key":"R17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.vaccine.2003.09.027","article-title":"Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults","volume":"22","author":"Fedson","year":"2004","journal-title":"Vaccine"},{"key":"R18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/341896","article-title":"Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines","volume":"35","author":"Feikin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R19","first-page":"6","article-title":"Invasive pneumococcal infection: England and Wales, 1999","volume":"11","author":"George","year":"2001","journal-title":"CDR Weekly"},{"key":"R20","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5694\/j.1326-5377.1993.tb121794.x","article-title":"An outbreak of serotype 1 Streptococcus pneumoniae infection in central Australia","volume":"158","author":"Gratten","year":"1993","journal-title":"Med J Aust"},{"key":"R21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/510249","article-title":"Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era","volume":"195","author":"Hanage","year":"2007","journal-title":"J Infect Dis"},{"key":"R22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, Part 1","volume":"30","author":"Hausdorff","year":"2000a","journal-title":"Clin Infect Dis"},{"key":"R23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":"The contribution of specific pneumococcal serogroups to different disease manisfestations: implications for conjugate vaccine formulation and use, Part II","volume":"30","author":"Hausdorff","year":"2000b","journal-title":"Clin Infect Dis"},{"key":"R24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/323339","article-title":"Dynamics of penicillin-susceptible clones in invasive pneumococcal disease","volume":"184","author":"Henriques Normark","year":"2001","journal-title":"J Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJM199409083311004","article-title":"An epidemic of pneumococcal disease in an over crowded, inadequately ventilated jail","volume":"331","author":"Hoge","year":"1994","journal-title":"N Engl J Med"},{"issue":"21","key":"R26","article-title":"Invasive pneumococcal infection, England and Wales: 2000","volume":"13","year":"2003","journal-title":"CDR Weekly"},{"key":"R27","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"volume-title":"Trends in incidence of pneumococcal disease before introduction of conjugate","year":"2007","author":"Ihekweazu","key":"R28"},{"key":"R29","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/520091","article-title":"Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks","volume":"196","author":"Jefferies","year":"2007","journal-title":"J Infect Dis"},{"key":"R30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/JCM.44.1.151-159.2006","article-title":"Identification of invasive serotype 1 streptococcal isolates that express nonhemolytic pneumolysin","volume":"44","author":"Kirkham","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"key":"R32","first-page":"358","article-title":"Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes and resistance","volume":"9","author":"Konradsen","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"R33","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.294.16.2043","article-title":"Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine","volume":"294","author":"Lexau","year":"2005","journal-title":"JAMA"},{"key":"R34","first-page":"17","article-title":"Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests","volume":"48 (Suppl. 1)","author":"MacGowan","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"R35","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1128\/JB.186.24.8181-8192.2004","article-title":"Evolutionary genetics of the capsular locus of serogroup 6 pneumococci","volume":"186","author":"Mavroidi","year":"2004","journal-title":"J Bacteriol"},{"key":"R36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinf.2005.02.008","article-title":"The current burden of pneumococcal disease in England and Wales","volume":"52","author":"Melegaro","year":"2006","journal-title":"J Infect"},{"key":"R37","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1086\/507699","article-title":"Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia","volume":"43","author":"Musher","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/pubmed\/fdl017","article-title":"Pneumococcal polysaccharide vaccine uptake in England, 1989-2003, prior to the introduction of a vaccination programme for older adults","volume":"28","author":"Noakes","year":"2006","journal-title":"J Public Health (Oxf)"},{"key":"R39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O'Brien","year":"2003","journal-title":"Lancet"},{"key":"R40","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1086\/498043","article-title":"Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States","volume":"192","author":"Pai","year":"2005","journal-title":"J Infect Dis"},{"key":"R41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/505710","article-title":"Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children","volume":"194","author":"Sleeman","year":"2006","journal-title":"J Infect Dis"},{"key":"R42","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.femsle.2004.11.015","article-title":"Displaying the relatedness among isolates of bacterial species - the eBURST approach","volume":"241","author":"Spratt","year":"2004","journal-title":"FEMS Microbiol Lett"},{"key":"R43","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med"},{"key":"R44","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R45","first-page":"117","article-title":"Pneumococcal vaccines; WHO position paper","volume":"74","year":"1999","journal-title":"Wkly Epidemiol Rec"},{"key":"R46","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization \u2013 WHO position paper","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.47690-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T05:15:36Z","timestamp":1601270136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jmm\/10.1099\/jmm.0.47690-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,1]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4,1]]}},"URL":"https:\/\/doi.org\/10.1099\/jmm.0.47690-0","relation":{},"ISSN":["0022-2615","1473-5644"],"issn-type":[{"type":"print","value":"0022-2615"},{"type":"electronic","value":"1473-5644"}],"subject":[],"published":{"date-parts":[[2008,4,1]]}}}